Cardiac cachexia is a multifaceted and severe syndrome characterized by the involuntary weight loss, muscle wasting, and debility seen in individuals grappling with chronic heart failure. This syndrome extends beyond simple weight reduction, involving a profound depletion of both lean body mass and fat reserves. Its management presents a considerable challenge in the context of heart failure, often resulting in heightened morbidity and mortality rates. The intricate mechanisms underlying cardiac cachexia encompass a intricate interplay of inflammatory processes, hormonal imbalances, and metabolic disruptions. Clinically, individuals afflicted by cardiac cachexia witness a decline in their functional capacity, coupled with a compromised quality of life. Approaches to managing this syndrome typically necessitate a multidisciplinary strategy, emphasizing nutritional support, exercise rehabilitation, and addressing the root causes of heart failure. Ongoing research delving into the pathophysiology and treatment avenues for cardiac cachexia aspires to deepen our comprehension and enhance the prognosis for those affected by this incapacitating syndrome.
Title : Investigating the long-term follow up of atrial septal device closures in wales and england: A comparative analysis with major adverse cardiovascular Events (MACE)
Meera Gopinath, Cardiff University Medical school, United Kingdom
Title : An adult case of polysplenia syndrome associated with sinus node dysfunction
Apoorva Tripathi, Oxford University Hospitals, United Kingdom
Title : A unique cell-driven phenomenon in the heart and the promising future of the innovative translational tools to manage cardiac self-renewal and regeneration
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Personalized and precision medicine (PPM) as a unique healthcare model through biodesign-driven translational applications and cardiology-related healthcare marketing to secure the human healthcare and biosafety
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Yasser’s criterion of inferior ST-segment discrepancy deviations in AF with aberrancy and Sgarbosa criteria - a new cardiovascular discovery and management - a case report
Yasser Mohammed Hassanain Elsayed, Egyptian Ministry of Health, Egypt